Home > Insider Trading > Filing (0000899243-18-029405)

Filing Details

Accession Number:: 0000899243-18-029405
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-19 21:00:37
Reporting Period:: 2018-11-15

Accepted Time:: 2018-11-19 21:00:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896262	Amedisys Inc	AMED	Services-Home Health Care Services (8082)	113131700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1689925	Paul Michael North	3854 American Way, Suite A Baton Rouge LA 70816	Chief Information Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-11-15	250	$32.56	21,753	No	4	M	Direct
Common Stock	Acquisiton	2018-11-15	5,625	$32.56	27,378	No	4	M	Direct
Common Stock	Disposition	2018-11-15	5,515	$120.20	21,863	No	4	S	Direct
Common Stock	Disposition	2018-11-15	360	$121.21	21,503	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-11-15	250	$0.00	250	$32.56
Common Stock	Stock Option (right to buy)	Disposition	2018-11-15	5,625	$0.00	5,625	$32.56

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,625		2025-06-02	No	4	M	Direct
0		2025-06-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	391	Indirect	Through 401(k) Plan

Footnotes

The total amount of shares beneficially owned includes 761 shares held in an employee stock purchase plan account.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.89, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.03 to $121.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The information in this report is based on a plan statement dated as of September 30, 2018.
On June 2, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The stock options are subject to time-based vesting conditions. 5,625 of the options vested on each of June 2, 2016, June 2, 2017 and June 2, 2018, and the remaining 5,625 options will vest on June 2, 2019, provided that the reporting person remains continuously employed by the Issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option.
On June 2, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2015 were met, resulting in vesting of the option as to 5,625 shares (the "2015 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2015 Tranche Options vested on June 2, 2016, one-third of the 2015 Tranche Options vested on June 2, 2017 and one-third of the 2015 Tranche Options vested on June 2, 2018.